Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8% | news.google.com • |
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA) | news.google.com • |
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8% | news.google.com • |
(SAVA) Technical Pivots with Risk Controls | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-05 | 2024-09 | -1.37 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | -0.44 | -1.28 | -0.84 | -190.91% |
2024-05-10 | 2024-03 | -0.51 | -1.41 | -0.9 | -176.47% |
2024-02-28 | 2023-12 | -0.4 | -0.5 | -0.1 | -25.00% |
2023-11-07 | 2023-09 | -0.9 | -0.61 | 0.29 | 32.22% |
2023-08-03 | 2023-06 | -0.58 | -0.63 | -0.05 | -8.62% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-23 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-02 | ARMISTICE CAPITAL L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-05-23 | BARBIER REMI | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
2024-04-22 | BARRY RICHARD J | Director | 0.00 | Conversion of Exercise of derivative security |
2022-10-02 | FRIEDMANN NADAV | Officer and Director | 80.05K | Conversion of Exercise of derivative security |
2023-04-30 | GUSSIN ROBERT Z | Director | 10.62K | Conversion of Exercise of derivative security |
2024-04-17 | KUPIEC JAMES WILLIAM | Officer | 4.00K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.75M | 67.35M | 6.54% |
2023-06-29 | Vanguard Group Inc | 2.25M | 55.16M | 5.36% |
2023-06-29 | State Street Corporation | 952.09K | 23.35M | 2.27% |
2023-06-29 | Geode Capital Management, LLC | 803.31K | 19.70M | 1.91% |
2023-06-29 | Gallacher Capital Management LLC | 583.29K | 14.30M | 1.39% |
2023-06-29 | Northern Trust Corporation | 370.64K | 9.09M | 0.88% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.23M | 30.21M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 908.42K | 19.05M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 542.35K | 13.30M | 1.29% |
2023-07-30 | Fidelity Small Cap Index Fund | 353.09K | 7.76M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 333.17K | 6.99M | 0.79% |
2023-05-30 | Fidelity Extended Market Index Fund | 202.34K | 4.60M | 0.48% |
Dividend | Date |
---|---|
0.75 | 2012-12-13 |
2 | 2010-12-13 |
Split | Date |
---|---|
1 : 7 | 2017-05-10 |
-
$SAVA like VKTG, once warrant bonus option clock begins ticking, Shorts will be in a seriously bad way…
-
$SAVA just like a tempered spring with downward pressure, the more it goes dow, the upward energy is being stored in those springs. Wouldn’t want to get caught short when those springs let loose…
-
Pretty firm resistance here, but the narrative is “Cheap Shares”… Money is where the data is. Can’t spin data, is what it is and SAVA is on to something and those who are resolved to the end will share the victory.
-
$SAVA Just a matter of time - $TNYA - Big day for Biotech!!!
-
Ohhh once those warrants are due….Shorts are majorly screwed…
-
Really a gift that the stock is so cheap for what it has to offer. At the very least, it should be easily over $40. 2 years ago and before the FUD campaign by shorts, the stock would have easily soared over $120. Buy and hold while you can, it wont be affordable very much longer.
-
$SAVA is so pulled back tensioned by short FUD that when the tension snaps, it will fly to the moon. The science speaks for itself…
-
Majority of stock held is retail holders! Wow! Buy more retailers, and dont sell for profit so easily…
-
Joe Springer is actually a real decent person from all I can tell. He offers a lot of information and insights to the biotech space. $SAVA
-
Good call Nick, Shorts are buying warrants to keep the price a cent or two in the red…Seems a bit petty and desperate.
-
$SAVA - Very confident this is my best investment, not only financially, but with a purpose. There isn’t any smoke and mirrors but from the Short campaign. Cassava is on the path to success, slow, steady, hold the line. Pay Day is coming soon.
-
$SAVA investing strategy 101: You buy the shares, hold. When it dips, buy more shares, hold. If a smudge article is created and the stock drops dramatically, you buy more shares and hold. No back 9 bitching, just buy the shares, believe the science and the organization and wait for the final data, or for early FDA approval. Quit watching obsessively for it to go up or down. Find another promising Biotech, and repeat. In fact, IF Biotechs are you thing, you should have 20 or more in your portfolio. Hopefully you choose well and build your wealth over time. Good luck!
-
$SAVA, interesting, SAVAW goes positive, SAVA goes negative, SAVAW goes negative, SAVA goes positive…
-
If I get this right: 2 exercise warrants: $66.00 in exchange for 3 SAVA Shares (Includes .5 bonus share for exercising), or 3 SAVA shares on the open market for Approx $74. Folks, make sure your warrants cant be loaned, hold them until CASSAVA SCIENCES announces when the bonus period will end. If you purchase Warrants @ $9.50 (2 for $19.00 + $66.00 to exercise) = 3 shares for $85. Still cheaper to hold warrants and buy on the open market. Nothing wrong with selling SAVA shares to exercise warrants as there is a $8.00 ROI pending no fees. Do I have that right? Any gains in SAVA just increase the selling of shares to exercise warrants. Holding Warrants until Cassava Sciences announces bonus days 20 dash expiration is an option play that any long should embrace.
-
OHHHH, would ya look it dat!!! $SAVA momentum -
-
-
$SAVA - nice desperate attempt to risk $$$ and double down shorting - Shorts will lose more then their shorts once they wake up from their dissonance. Truth is a bitch when you are on the wrong side of it.
-
@LarryRosen Springer posted he is making upgrades this week. Will be back next week.
-
I hope all you asshole shorts end up with Alzheimer’s one day. It doesn’t matter what company it is nowadays, shorts are trying to kill companies,i realize they are necessary in the market, however, they have become a plague that has gotten out of hand.
-
To those of you on the wrong side of this investment, live, learn, reset, and move forward. If you are losing it all, you have just as much ability to gain it all back with some wit and humility. Congrats to the longs for sticking around the last 2.5 years, we will have our day to celebrate. Hope you all find a nice charity to help alleviate some taxes on your gains once you decide to sell. $SAVA to the moon!!
-
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8%
news.google.com • -
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA)
news.google.com • -
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8%
news.google.com • -
(SAVA) Technical Pivots with Risk Controls
news.google.com •